About Planet Biopharmaceuticals
Planet Biopharmaceuticals is a company based in Ridgefield (United States) founded in 1968 was acquired by Waypoint Capital in April 2013. Planet Biopharmaceuticals operates in a competitive market with competitors including HOOKIPA Pharma, Valneva, Stallergenes Greer, IgGenix and Immunomic Therapeutics, among others.
- Headquarter Ridgefield, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Waypoint Capital
(Apr 15, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Planet Biopharmaceuticals
Detailed funding history for Planet Biopharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Planet Biopharmaceuticals
Planet Biopharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include B-FLEXION.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
B-FLEXION is recognized as a private entrepreneurial investment firm.
|
Locked | Locked | Locked |
Investor details for Planet Biopharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Planet Biopharmaceuticals
Investment portfolio details for Planet Biopharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Planet Biopharmaceuticals
Detailed financials for Planet Biopharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Planet Biopharmaceuticals Comparisons
Peer comparison for Planet Biopharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Planet Biopharmaceuticals
Planet Biopharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HOOKIPA Pharma, Valneva, Stallergenes Greer, IgGenix and Immunomic Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| Locked | Locked | Locked |
Prophylactic vaccines for infectious diseases are developed and advanced.
|
|
| Locked | Locked | Locked |
Allergen immunotherapies for respiratory allergies are developed.
|
|
| Locked | Locked | Locked |
Therapeutic solutions for food allergies are developed via antibody platforms.
|
|
| Locked | Locked | Locked |
Immunomic Therapeutics is engaged in developing nucleic acid immunotherapy platforms.
|
|
| Locked | Locked | Locked |
Danish, Public Biopharma company developing allergy immunotherapies including injections (emergency) and sublingual tablets.
|
Detailed competitors of Planet Biopharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Planet Biopharmaceuticals
Complete news archive for Planet Biopharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Planet Biopharmaceuticals
Planet Biopharmaceuticals was founded in 1968.
Planet Biopharmaceuticals is headquartered in Ridgefield, United States.
Founded in 1968, Planet Biopharmaceuticals is based in Ridgefield, United States, within the biopharmaceutical sector. Allergenic extracts addressing allergens such as eight kinds of grass, house dust mites, cat hair, and short ragweed at 100,000 AUmL are offered. A spirometer for asthma diagnosis was added recently. Comprehensive allergenic extract options are maintained for the U.S. market, with services extended to ENT specialists over decades.
Planet Biopharmaceuticals's top competitors include HOOKIPA Pharma, Stallergenes Greer and Valneva.
Planet Biopharmaceuticals has 1 investor. Key investors include B-FLEXION.